2. a)SECUENCIA REVERSA
TTCACGTTGTGGTGTTACAAGCGCGTACCAGGGGGTGGCGTGATGACTGACCCGGGATTCGACGAACTGACACGTCTAGTCTG CCCTACGTCATAAAAGTCGAACCATACCAGCGTGTATTCACGTTGTGGTGTTACAAGCGCGTACCAGGGGGTGGCGTGATGACT GACCCGGGATTCGACGAACTGACACGTCTAGTCTGCCCTACGTCATAAAAGTCGAACCATACCAGCGTGTATTCACGTTGTGGT GTTACAAGCGCGTACCAGGGGGTGGCGTGATGACTGACCCGGGATTCGACGAACTGACACGTCTAGTCTGCCCTACGTCATAA AAGTCGAACCATACCAGCGTGTATTCACGTTGTGGTGTTACAAGCGCGTACCAGGGGGTGGCGTGATGACTGACCCGGGATTC GACGAACTGACACGTCTAGTCTGCCCTACGTCATAAAAGTCGAACCATACCAGCGTGTA
b)SECUENCIA COMPLEMENTARIA
TACACGCTGGTATGGTTCGACTTTTATGACGTAGGGCAGACTAGACGTGTCAGTTCGTCGAATCCCGGGTCAGTCATCACGCCA CCCCCTGGTACGCGCTTGTAACACCACAACGTGAATACACGCTGGTATGGTTCGACTTTTATGACGTAGGGCAGACTAGACGTG TCAGTTCGTCGAATCCCGGGTCAGTCATCACGCCACCCCCTGGTACGCGCTTGTAACACCACAACGTGAATACACGCTGGTATG GTTCGACTTTTATGACGTAGGGCAGACTAGACGTGTCAGTTCGTCGAATCCCGGGTCAGTCATCACGCCACCCCCTGGTACGCG CTTGTAACACCACAACGTGAATACACGCTGGTATGGTTCGACTTTTATGACGTAGGGCAGACTAGACGTGTCAGTTCGTCGAAT CCCGGGTCAGTCATCACGCCACCCCCTGGTACGCGCTTGTAACACCACAACGTGAA
c)ARN
AUGUGCGACCAUACCAAGCUGAAAAUACUGCAUCCCGUCUGAUCUGCACAGUCAAGCAGCUUAGGGCCCAGUCAGUAGU GCGGUGGGGGACCAUGCGCGAACAUUGUGGUGUUGCACUUAUGUGCGACCAUACCAAGCUGAAAAUACUGCAUCCCGUC UGAUCUGCACAGUCAAGCAGCUUAGGGCCCAGUCAGUAGUGCGGUGGGGGACCAUGCGCGAACAUUGUGGUGUUGCAC UUAUGUGCGACCAUACCAAGCUGAAAAUACUGCAUCCCGUCUGAUCUGCACAGUCAAGCAGCUUAGGGCCCAGUCAGUA GUGCGGUGGGGGACCAUGCGCGAACAUUGUGGUGUUGCACUUAUGUGCGACCAUACCAAGCUGAAAAUACUGCAUCCCG UCUGAUCUGCACAGUCAAGCAGCUUAGGGCCCAGUCAGUAGUGCGGUGGGGGACCAUGCGCGAACAUUGUGGUGUUGC ACUU
d)PROTENA CODIFICADA
RF1 : MCDHTKLKILHPV*SAQSSSLGPSQ*CGGGPCANIVVLHL CATIPS*KYCIPSDLHSQAA*GPVSSAVGDHARTLWCCTY VRPYQAENTASRLICTVKQLRAQSVVRWGTMREHCGVALM CDHTKLKILHPV*SAQSSSLGPSQ*CGGGPCANIVVLH RF2 : CATIPS*KYCIPSDLHSQAA*GPVSSAVGDHARTLWCCTY VRPYQAENTASRLICTVKQLRAQSVVRWGTMREHCGVALM CDHTKLKILHPV*SAQSSSLGPSQ*CGGGPCANIVVLHLC ATIPS*KYCIPSDLHSQAA*GPVSSAVGDHARTLWCCT RF3: VRPYQAENTASRLICTVKQLRAQSVVRWGTMREHCGVALM CDHTKLKILHPV*SAQSSSLGPSQ*CGGGPCANIVVLHLC ATIPS*KYCIPSDLHSQAA*GPVSSAVGDHARTLWCCTYV RPYQAENTASRLICTVKQLRAQSVVRWGTMREHCGVAL
Pgina 1
e)RESULTADOS:
Porcentaje de nucletidos A: 112 nucletidos 23,52% C: 120 nucletidos 25,21% G: 136 nucletidos 28,57% T: 108 nucletidos 22,68%
30 25 20 15 10 5 0 A C G T
Porcentaje de dmeros AA: 24 dmeros 5.04% AC: 28 dmeros 5.88% AG: 32 dmeros 6.72% AT: 28 dmeros 5.88% CA: 48 dmeros 10.08% CC: 28 dmeros 5.88% CG: 20 dmeros 4.2% CT: 24 dmeros 5.04% GA: 20 dmeros 4.2% GC: 44 dmeros 9.24% GG: 32 dmeros 6.72% GT: 40 dmeros 8.4% TA: 19 dmeros 3.99% TC: 20 dmeros 4.2% TG: 52 dmeros 10.92% TT: 16 dmeros 3.36%
Pgina 2
3.FUENTES USADAS:
http://personales.upv.es/jcanizar/bioinformatica/conocimientos_previos.html http://www.dnalc.org/resources/geneboy.html http://www.genome.gov/GlossaryS/index.cfm?id=146 http://www.marcoregalia.com/STUFF/UDISTRITAL/Bioinformatica/Actividades/Resumenes%20Clases/Openreadingf rames.html
Pgina 3